CA Stock MarketDetailed Quotes

BCT BriaCell Therapeutics Corp

Watchlist
  • 0.760
  • -0.020-2.56%
15min DelayMarket Closed Dec 24 13:00 ET
33.60MMarket Cap-0.61P/E (TTM)

BriaCell Therapeutics Corp Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Oct 31, 2024
(FY)Jul 31, 2024
(Q4)Jul 31, 2024
(Q3)Apr 30, 2024
(Q2)Jan 31, 2024
(Q1)Oct 31, 2023
(FY)Jul 31, 2023
(Q4)Jul 31, 2023
(Q3)Apr 30, 2023
(Q2)Jan 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-39.40%5.15M
43.22%33.33M
-25.15%5.77M
62.58%9.23M
119.10%9.83M
57.37%8.5M
52.25%23.27M
47.22%7.71M
37.68%5.68M
23.13%4.49M
Selling and administrative expenses
-9.62%1.49M
-22.47%6.15M
-46.32%1.36M
-13.46%1.57M
9.70%1.57M
-23.38%1.65M
9.19%7.94M
22.91%2.54M
-2.05%1.82M
-26.08%1.43M
-General and administrative expense
-9.62%1.49M
-22.47%6.15M
-46.32%1.36M
-13.46%1.57M
9.70%1.57M
-23.38%1.65M
9.19%7.94M
22.91%2.54M
-2.05%1.82M
-26.08%1.43M
Research and development costs
-46.55%3.67M
77.21%27.18M
-14.75%4.41M
98.36%7.66M
170.44%8.26M
110.65%6.86M
91.19%15.34M
63.07%5.17M
70.16%3.86M
78.75%3.05M
Operating profit
39.40%-5.15M
-43.22%-33.33M
25.15%-5.77M
-62.58%-9.23M
-119.10%-9.83M
-57.37%-8.5M
-52.25%-23.27M
-47.22%-7.71M
-37.68%-5.68M
-23.13%-4.49M
Net non-operating interest income (expenses)
-93.16%13.05K
-67.68%288.02K
-100.00%2
-93.84%15.61K
-66.09%81.6K
1.31%190.82K
556.50%891.21K
153.50%208.78K
604.39%253.49K
1,891.52%240.6K
Non-operating interest income
-93.16%13.05K
-67.68%288.02K
-100.00%2
-93.84%15.61K
-66.09%81.6K
1.31%190.82K
551.80%891.21K
153.50%208.78K
604.39%253.49K
1,891.52%240.6K
Other net income (expenses)
-104.83%-689.49K
1,252.34%28.11M
-11.01%4.52M
1,965.18%10.91M
79.23%-1.59M
247.38%14.27M
117.78%2.08M
8.02%5.08M
108.91%528.1K
-151.62%-7.64M
Gain on sale of security
-104.33%-617.98K
1,257.46%28.22M
-10.00%4.57M
1,972.18%10.94M
79.47%-1.57M
247.38%14.27M
117.78%2.08M
8.02%5.08M
108.91%528.1K
-151.62%-7.64M
Income before tax
-197.83%-5.83M
75.71%-4.93M
48.37%-1.25M
134.57%1.69M
4.61%-11.33M
638.51%5.96M
24.35%-20.3M
-437.06%-2.42M
51.12%-4.9M
-206.46%-11.88M
Income tax
Earnings from equity interest net of tax
Net income
-197.83%-5.83M
75.71%-4.93M
48.37%-1.25M
134.57%1.69M
4.61%-11.33M
638.51%5.96M
24.35%-20.3M
-437.06%-2.42M
51.12%-4.9M
-206.46%-11.88M
Net income continuous operations
-197.83%-5.83M
75.71%-4.93M
48.37%-1.25M
134.57%1.69M
4.61%-11.33M
638.51%5.96M
24.35%-20.3M
-437.06%-2.42M
51.12%-4.9M
-206.46%-11.88M
Noncontrolling interests
36.49%-27.1K
-140.08K
-34.59K
-23.52K
-39.31K
-42.67K
0
0
0
0
Net income attributable to the company
-196.68%-5.8M
76.40%-4.79M
49.80%-1.21M
135.05%1.72M
4.94%-11.29M
642.37%6M
24.35%-20.3M
-437.06%-2.42M
51.12%-4.9M
-206.46%-11.88M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-196.68%-5.8M
76.40%-4.79M
49.80%-1.21M
135.05%1.72M
4.94%-11.29M
642.37%6M
24.35%-20.3M
-437.06%-2.42M
51.12%-4.9M
-206.46%-11.88M
Diluted earnings per share
-157.89%-0.22
77.69%-0.29
53.33%-0.07
134.38%0.11
7.79%-0.71
642.86%0.38
24.86%-1.3
-400.00%-0.15
50.77%-0.32
-208.45%-0.77
Basic earnings per share
56.00%-0.22
77.69%-0.29
53.33%-0.07
134.38%0.11
7.79%-0.71
-614.29%-0.5
24.86%-1.3
-400.00%-0.15
50.77%-0.32
-208.45%-0.77
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Oct 31, 2024(FY)Jul 31, 2024(Q4)Jul 31, 2024(Q3)Apr 30, 2024(Q2)Jan 31, 2024(Q1)Oct 31, 2023(FY)Jul 31, 2023(Q4)Jul 31, 2023(Q3)Apr 30, 2023(Q2)Jan 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -39.40%5.15M43.22%33.33M-25.15%5.77M62.58%9.23M119.10%9.83M57.37%8.5M52.25%23.27M47.22%7.71M37.68%5.68M23.13%4.49M
Selling and administrative expenses -9.62%1.49M-22.47%6.15M-46.32%1.36M-13.46%1.57M9.70%1.57M-23.38%1.65M9.19%7.94M22.91%2.54M-2.05%1.82M-26.08%1.43M
-General and administrative expense -9.62%1.49M-22.47%6.15M-46.32%1.36M-13.46%1.57M9.70%1.57M-23.38%1.65M9.19%7.94M22.91%2.54M-2.05%1.82M-26.08%1.43M
Research and development costs -46.55%3.67M77.21%27.18M-14.75%4.41M98.36%7.66M170.44%8.26M110.65%6.86M91.19%15.34M63.07%5.17M70.16%3.86M78.75%3.05M
Operating profit 39.40%-5.15M-43.22%-33.33M25.15%-5.77M-62.58%-9.23M-119.10%-9.83M-57.37%-8.5M-52.25%-23.27M-47.22%-7.71M-37.68%-5.68M-23.13%-4.49M
Net non-operating interest income (expenses) -93.16%13.05K-67.68%288.02K-100.00%2-93.84%15.61K-66.09%81.6K1.31%190.82K556.50%891.21K153.50%208.78K604.39%253.49K1,891.52%240.6K
Non-operating interest income -93.16%13.05K-67.68%288.02K-100.00%2-93.84%15.61K-66.09%81.6K1.31%190.82K551.80%891.21K153.50%208.78K604.39%253.49K1,891.52%240.6K
Other net income (expenses) -104.83%-689.49K1,252.34%28.11M-11.01%4.52M1,965.18%10.91M79.23%-1.59M247.38%14.27M117.78%2.08M8.02%5.08M108.91%528.1K-151.62%-7.64M
Gain on sale of security -104.33%-617.98K1,257.46%28.22M-10.00%4.57M1,972.18%10.94M79.47%-1.57M247.38%14.27M117.78%2.08M8.02%5.08M108.91%528.1K-151.62%-7.64M
Income before tax -197.83%-5.83M75.71%-4.93M48.37%-1.25M134.57%1.69M4.61%-11.33M638.51%5.96M24.35%-20.3M-437.06%-2.42M51.12%-4.9M-206.46%-11.88M
Income tax
Earnings from equity interest net of tax
Net income -197.83%-5.83M75.71%-4.93M48.37%-1.25M134.57%1.69M4.61%-11.33M638.51%5.96M24.35%-20.3M-437.06%-2.42M51.12%-4.9M-206.46%-11.88M
Net income continuous operations -197.83%-5.83M75.71%-4.93M48.37%-1.25M134.57%1.69M4.61%-11.33M638.51%5.96M24.35%-20.3M-437.06%-2.42M51.12%-4.9M-206.46%-11.88M
Noncontrolling interests 36.49%-27.1K-140.08K-34.59K-23.52K-39.31K-42.67K0000
Net income attributable to the company -196.68%-5.8M76.40%-4.79M49.80%-1.21M135.05%1.72M4.94%-11.29M642.37%6M24.35%-20.3M-437.06%-2.42M51.12%-4.9M-206.46%-11.88M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -196.68%-5.8M76.40%-4.79M49.80%-1.21M135.05%1.72M4.94%-11.29M642.37%6M24.35%-20.3M-437.06%-2.42M51.12%-4.9M-206.46%-11.88M
Diluted earnings per share -157.89%-0.2277.69%-0.2953.33%-0.07134.38%0.117.79%-0.71642.86%0.3824.86%-1.3-400.00%-0.1550.77%-0.32-208.45%-0.77
Basic earnings per share 56.00%-0.2277.69%-0.2953.33%-0.07134.38%0.117.79%-0.71-614.29%-0.524.86%-1.3-400.00%-0.1550.77%-0.32-208.45%-0.77
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Price
% Chg

No Data